544 related articles for article (PubMed ID: 9572491)
1. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A
Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491
[TBL] [Abstract][Full Text] [Related]
2. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.
Goetz F; Tzeng YJ; Guhl E; Merker J; Graessmann M; Graessmann A
Oncogene; 2001 Apr; 20(18):2325-32. PubMed ID: 11402328
[TBL] [Abstract][Full Text] [Related]
3. SV40 T-antigen induces breast cancer formation with a high efficiency in lactating and virgin WAP-SV-T transgenic animals but with a low efficiency in ovariectomized animals.
Santarelli R; Tzeng YJ; Zimmermann C; Guhl E; Graessmann A
Oncogene; 1996 Feb; 12(3):495-505. PubMed ID: 8637705
[TBL] [Abstract][Full Text] [Related]
4. Expression of a viral oncoprotein during mammary gland development alters cell fate and function: induction of p53-independent apoptosis is followed by impaired milk protein production in surviving cells.
Li M; Hu J; Heermeier K; Hennighausen L; Furth PA
Cell Growth Differ; 1996 Jan; 7(1):3-11. PubMed ID: 8788028
[TBL] [Abstract][Full Text] [Related]
5. HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53.
Klein A; Guhl E; Tzeng YJ; Fuhrhop J; Levrero M; Graessmann M; Graessmann A
Oncogene; 2003 May; 22(19):2910-9. PubMed ID: 12771941
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer formation in transgenic animals induced by the whey acidic protein SV40 T antigen (WAP-SV-T) hybrid gene.
Tzeng YJ; Guhl E; Graessmann M; Graessmann A
Oncogene; 1993 Jul; 8(7):1965-71. PubMed ID: 8390039
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways.
Li M; Hu J; Heermeier K; Hennighausen L; Furth PA
Cell Growth Differ; 1996 Jan; 7(1):13-20. PubMed ID: 8788029
[TBL] [Abstract][Full Text] [Related]
8. A transgenic mouse model for mammary carcinogenesis.
Li B; Murphy KL; Laucirica R; Kittrell F; Medina D; Rosen JM
Oncogene; 1998 Feb; 16(8):997-1007. PubMed ID: 9519874
[TBL] [Abstract][Full Text] [Related]
9. WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis.
Li M; Lewis B; Capuco AV; Laucirica R; Furth PA
Oncogene; 2000 Feb; 19(8):1010-9. PubMed ID: 10713684
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic mechanisms affect mutant p53 transgene expression in WAP-mutp53 transgenic mice.
Krepulat F; Löhler J; Heinlein C; Hermannstädter A; Tolstonog GV; Deppert W
Oncogene; 2005 Jul; 24(29):4645-59. PubMed ID: 15870706
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy resistance of mouse WAP-SVT/t breast cancer cells is mediated by osteopontin, inhibiting apoptosis downstream of caspase-3.
Graessmann M; Berg B; Fuchs B; Klein A; Graessmann A
Oncogene; 2007 May; 26(20):2840-50. PubMed ID: 17160024
[TBL] [Abstract][Full Text] [Related]
12. Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis.
Hadsell DL; Murphy KL; Bonnette SG; Reece N; Laucirica R; Rosen JM
Oncogene; 2000 Feb; 19(7):889-98. PubMed ID: 10702797
[TBL] [Abstract][Full Text] [Related]
13. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH
Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493
[TBL] [Abstract][Full Text] [Related]
14. The three transforming regions of SV40 T antigen are required for immortalization of primary mouse embryo fibroblasts.
Conzen SD; Cole CN
Oncogene; 1995 Dec; 11(11):2295-302. PubMed ID: 8570180
[TBL] [Abstract][Full Text] [Related]
15. An unexpected role for p53 in augmenting SV40 large T antigen-mediated tumorigenesis.
Herzig M; Novatchkova M; Christofori G
Biol Chem; 1999 Feb; 380(2):203-11. PubMed ID: 10195427
[TBL] [Abstract][Full Text] [Related]
16. Ectopic TGF beta 1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population.
Kordon EC; McKnight RA; Jhappan C; Hennighausen L; Merlino G; Smith GH
Dev Biol; 1995 Mar; 168(1):47-61. PubMed ID: 7883078
[TBL] [Abstract][Full Text] [Related]
17. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
[TBL] [Abstract][Full Text] [Related]
19. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.
Morini M; Astigiano S; Mora M; Ricotta C; Ferrari N; Mantero S; Levi G; Rossini M; Barbieri O
Oncogene; 2000 Dec; 19(52):6007-14. PubMed ID: 11146552
[TBL] [Abstract][Full Text] [Related]
20. The SV40 T-antigen induces premature apoptotic mammary gland involution during late pregnancy in transgenic mice.
Tzeng YJ; Gottlob K; Santarelli R; Graessmann A
FEBS Lett; 1996 Feb; 380(3):215-8. PubMed ID: 8601427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
